Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy
- 29 March 2010
- journal article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 24 (6) , 968-974
- https://doi.org/10.1016/j.bbi.2010.03.009
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Inflammatory Biomarkers and Fatigue during Radiation Therapy for Breast and Prostate CancerClinical Cancer Research, 2009
- Serum interleukin‐6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantationCancer, 2008
- Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With CancerJournal of Clinical Oncology, 2008
- Longitudinal Study of the Relationship Between Chemoradiation Therapy for Non–Small-Cell Lung Cancer and Patient SymptomsJournal of Clinical Oncology, 2006
- Cancer Symptom Assessment Instruments: A Systematic ReviewJournal of Clinical Oncology, 2006
- Symptom Cluster Research: Conceptual, Design, Measurement, and Analysis IssuesJournal of Pain and Symptom Management, 2006
- Occurrence, Severity, and Longitudinal Course of Twelve Common Symptoms in 1129 Consecutive Patients During Radiotherapy for CancerJournal of Pain and Symptom Management, 2005
- A Cytokine-Based Neuroimmunologic Mechanism of Cancer-Related SymptomsNeuroimmunomodulation, 2004
- Cancer-related symptomsSeminars in Radiation Oncology, 2000
- Mass spectral determination of long-chain quaternary amines in mixturesAnalytica Chimica Acta, 1982